Conduct your critical NSCLC research without the worry of finding respondents. Rare Patient Voice offers our NSCLC survey panel to help you undertake your study by providing you with qualified, eligible participants.
Our extensive panel of patients diagnosed with NSCLC can help you acquire the data you need to make informed decisions on your research. By using our survey panel, we can save you time and money by expediting the process of recruiting participants for your lung cancer clinical trial. We ensure that our respondents are suited to your study and will provide a representative sample of the population. Each patient or family caregiver is carefully vetted to ensure we have the right respondents for your study.
We understand the challenges facing rare disease researchers, especially in terms of identifying and recruiting participants for your studies. Rare Patient Voices helps to fill that gap through our growing network of patients and family caregivers.
Informed Consent
Informed consent for NSCLC clinical trials ensures that patients fully understand the procedures, potential risks, and benefits of participating. Our process requires clear communication, fostering a safe and transparent environment wherein patients can make fully informed decisions about their participation.
We provide detailed information about the trial to ensure patients know what they’re signing up for.
RPV also aims to create a smooth, secure experience for researchers and participants alike. Let us help take the guesswork out of conducting your research while providing a top-notch service that researchers and patients can rely on.
Eligibility for NSCLC Clinical Trials
Eligibility for NSCLC clinical trials is determined through a thorough medical evaluation of each potential participant. This evaluation typically includes reviewing the patient’s medical history, current health status, and specific characteristics of their NSCLC diagnosis. The clinical site team performs such evaluations.
Factors such as the stage of the disease, previous treatments, age, genetic markers, and overall health are all considered when assessing eligibility. It’s important to note that criteria for participation can vary significantly from one clinical trial to another, depending on the research question and objectives of the study.
Take Part in Research
If you are a non-small cell lung cancer patient or a family caregiver, you can take part in the research studies that are moving the industry forward. Your input will help researchers and companies developing new treatments and services, and you will also be paid for your participation. Sign up with us here and take part as a NSCLC research participant.
